Satellite Adaptive Tissue
Bioprinting Startup Satellite Bio Exits Stealth with Ex-Novartis Exec as CEO
After years in the making, biotech research firm Satellite Bio emerged from stealth mode last week with more than $110 million in financing to pioneer an entirely new category of…